Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abbott, K. C.
Right arrow Articles by Kimmel, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abbott, K. C.
Right arrow Articles by Kimmel, P. L.
J Am Soc Nephrol 15:1633-1639, 2004
© 2004 American Society of Nephrology


CLINICAL SCIENCE

Human Immunodeficiency Virus Infection and Kidney Transplantation in the Era of Highly Active Antiretroviral Therapy and Modern Immunosuppression

Kevin C. Abbott*, S. John Swanson{dagger}, Lawrence Y.C. Agodoa{ddagger} and Paul L. Kimmel, MD§

*Nephrology Service, Walter Reed Army Medical Center (WRAMC), Washington, DC, and Uniformed Services University School of the Health Sciences, Bethesda, MD; {dagger}Organ Transplant Service, WRAMC, Washington, DC, and National Institutes of Health, Bethesda, MD; {ddagger}NIDDK, National Institutes of Health, Bethesda, MD; and §Division of Kidney Diseases and Hypertension, Department of Medicine, George Washington University Medical Center, Washington, DC.

Correspondence to Dr. Kevin C. Abbott, Nephrology Service, Walter Reed Army Medical Center, Washington, DC 20307-5001. Phone: 202-782-6462/6463/6288; Fax: 202-782-0185; E-mail: kevin.abbott{at}na.amedd.army.mil

ABSTRACT. Before the era of highly active antiretroviral therapy, kidney transplant recipients infected with HIV had increased risk of death compared with HIV-uninfected recipients. More recent single-center reports have indicated improved results, but this has not been assessed in a national population. Therefore, a retrospective cohort study of US adult deceased donor kidney transplant recipients from January 1, 1996, to May 31, 2001 was conducted; patients were followed until October 31, 2001. A total of 27,851 patients had valid recipient HIV serology. Cox regression analysis was used to model adjusted hazard ratios for mortality and graft loss, respectively, adjusted for other factors, including comorbid conditions from Centers for Medicare and Medicaid Studies Form 2728. Factors independently associated with HIV infection were also assessed by logistic regression analysis. Only 12.8% of HIV-infected recipients were black, compared with 27.6% in the entire study cohort. HIV-infected kidney transplant recipients were significantly less likely to be black in logistic regression analysis (adjusted OR, 0.29; 95% CI, 0.08 to 0.99; P = 0.049), which was the only factor independently associated with HIV infection. It was found that HIV-infected recipients had improved survival compared with HIV-uninfected recipients, although this was not statistically significant in adjusted analysis (adjusted HR, 0.36; 95% CI, 0.05 to 2.53; P = 0.31). Kidney transplantation in HIV-infected patients is plausible and ongoing, but HIV-infected candidates who underwent kidney transplantation in the United States during the course of the study were demographically unrepresentative of HIV-infected candidates generally.




This article has been cited by other articles:


Home page
JCOHome page
G. C. Persad, R. F. Little, and C. Grady
Including Persons With HIV Infection in Cancer Clinical Trials
J. Clin. Oncol., March 1, 2008; 26(7): 1027 - 1032.
[Full Text] [PDF]


Home page
CJASNHome page
B. C. Weikert and E. A. Blumberg
Viral Infection after Renal Transplantation: Surveillance and Management
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(Supplement_2): S76 - S86.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
J. S. Berns and N. Kasbekar
Highly Active Antiretroviral Therapy and the Kidney: An Update on Antiretroviral Medications for Nephrologists
Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 117 - 129.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. L. Lentine, D. C. Brennan, and M. A. Schnitzler
Incidence and Predictors of Myocardial Infarction after Kidney Transplantation
J. Am. Soc. Nephrol., February 1, 2005; 16(2): 496 - 506.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP